Literature DB >> 2972366

Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytes.

H Shau1, J D Gray, S H Golub.   

Abstract

High levels of cytotoxic activity against the natural killer (NK) cell-sensitive target K562 and the NK-resistant target UCLA-SO-M14 (M14) can be generated in vitro either by mixed lymphocyte culture (MLC) or by culture of lymphocytes in interleukin 2 (IL2) (lymphokine activated killer (LAK) cells). The purpose of this study was to identify similarities and differences between MLC-LAK and IL2-LAK cells and allospecific cytotoxic T cells. Induction of cytotoxicity against K562 and M14 in both culture systems was inhibited by antibodies specific either for IL2 or the Tac IL2 receptor. Like NK effector cells, the precursors for the MLC-LAK cells were low density large lymphocytes. However these precursors differed from the large granular lymphocytes that mediated NK cytolysis in sensitivity to the toxic lysosomotropic agent L-leucine methyl ester (LME). The resistance of the MLC-LAK precursors to LME indicated that the precursors included large agranular lymphocytes. Although interferon-gamma (IFN-gamma) is produced in MLC and in IL2 containing cultures, it is not required for induction of either type of cytotoxic activity. Neutralization of IFN-gamma in MLC- and IL2-containing cultures with specific antibodies had no effect on the induction of cytotoxic activities. Both allospecific cytotoxic T lymphocyte (CTL) and LAK activities were enhanced by IL2 and IFN-gamma at the effector cell stage. However, the mechanism of cytolysis was different in the two systems. NK- and MLC-induced LAK activities were independent of CD3-T cell receptor complex while CTL activity was blocked by monoclonal antibodies specific for the CD3 antigen. These results suggest that NK and the in vitro induced LAK cytotoxicities are a family of related functions that differ from CTL. Furthermore, MLC-induced and IL2-induced cytotoxicities against K562 and M14 appear to be identical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972366     DOI: 10.1007/bf00205448

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  45 in total

1.  Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.

Authors:  M R Potter; M Moore; A G Morris
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

2.  Identification and purification of NK cells with lysosomotropic vital stains: correlation of lysosome content with NK activity.

Authors:  H Shau; J R Dawson
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

3.  Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity.

Authors:  V David; J F Bourge; P Guglielmi; D Mathieu-Mahul; L Degos; A Bensussan
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

4.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

Authors:  H Rabin; R F Hopkins; F W Ruscetti; R H Neubauer; R L Brown; T G Kawakami
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor.

Authors:  S C Meuer; O Acuto; R E Hussey; J C Hodgdon; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.

Authors:  J M Depper; W J Leonard; R J Robb; T A Waldmann; W C Greene
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

7.  Functional studies on the precursors of human lymphokine-activated killer cells.

Authors:  J D Gray; H Y Shau; S H Golub
Journal:  Cell Immunol       Date:  1985-12       Impact factor: 4.868

8.  Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

Authors:  A H Rook; J J Hooks; G V Quinnan; H C Lane; J F Manischewitz; A M Macher; H Masur; A S Fauci; J Y Djeu
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

9.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Authors:  U Landegren; U Ramstedt; I Axberg; M Ullberg; M Jondal; H Wigzell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  6 in total

1.  High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.

Authors:  H Tanaka; M Hori; T Ohki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.

Authors:  R De Jong; M Brouwer; V I Rebel; G A Van Seventer; F Miedema; R A Van Lier
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

3.  Immunopathological features of human pulmonary tumors following low-dose interleukin-2.

Authors:  S G Swisher; T M Anderson; D R Wen; M A Stene; A J Cochran; S H Golub; E C Holmes
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.

Authors:  G Pawelec; H Schmidt; A Rehbein; F Busch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity.

Authors:  N Ebina; D Gallardo; H Shau; S H Golub
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

6.  Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.

Authors:  B Leshem; E Kedar
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.